NUTEX — Nutex Befektetesi Nyrt Share Price
- HUF3.09bn
- -HUF1.98bn
- HUF0.45m
- 50
- 28
- 59
- 39
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.54 | ||
Price to Tang. Book | 0.54 | ||
Price to Free Cashflow | 100.46 | ||
Price to Sales | 6,864.47 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -0.33% | ||
Return on Equity | 8.42% | ||
Operating Margin | -4267.33% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HUFm | 0.75 | 0.45 | 0.45 | 0.45 | 0.45 | n/a | n/a | -35.81% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | -76.52 | +952.45 | +28.16 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
NUTEX Befektetesi Nyrt is a Hungary-based company engaged in the research, development, manufacturing and distribution of medicinal products. Together with its daughter companies it forms Nutex Group. The Group also provides to its consumers health conserving, health improving, dietary supplement and cosmetic products. Its brand names include Enerex and Organic Mission. NUTEX Befektetesi Nyrt operates in Hungary, Slovakia and the United Kingdom, as well as in Canada, Taiwan, Iran, the United Arab Emirates, Mexico and Hong Kong.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- May 29th, 1996
- Public Since
- July 25th, 1996
- No. of Employees
- 1
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Budapest Stock Exchange
- Shares in Issue
- 158,410,766

- Address
- Telepes u. 53., BUDAPEST, 1147
- Web
- http://www.nutex.hu/
- Phone
- +36 18017081
- Auditors
- INTERAUDITOR Kft
Upcoming Events for NUTEX
Nutex Befektetesi Nyrt Annual Shareholders Meeting
Nutex Befektetesi Nyrt Extraordinary Shareholders Meeting
Similar to NUTEX
Richter Gedeon Vegyeszeti Gyar Nyrt
Budapest Stock Exchange
Goodwill Pharma Orvos es Gyogyszertudomanyi Nyrt
Budapest Stock Exchange
Naturland Holding Vagyonkezelo es Befektetesi Nyrt
Budapest Stock Exchange
FAQ
As of Today at 22:22 UTC, shares in Nutex Befektetesi Nyrt are trading at HUF19.50. This share price information is delayed by 15 minutes.
Shares in Nutex Befektetesi Nyrt last closed at HUF19.50 and the price had moved by +36.84% over the past 365 days. In terms of relative price strength the Nutex Befektetesi Nyrt share price has outperformed the FTSE Global All Cap Index by +34.43% over the past year.
There is no consensus recommendation for this security.
Find out moreNutex Befektetesi Nyrt does not currently pay a dividend.
Nutex Befektetesi Nyrt does not currently pay a dividend.
Nutex Befektetesi Nyrt does not currently pay a dividend.
To buy shares in Nutex Befektetesi Nyrt you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HUF19.50, shares in Nutex Befektetesi Nyrt had a market capitalisation of HUF3.09bn.
Here are the trading details for Nutex Befektetesi Nyrt:
- Country of listing: Hungary
- Exchange: BUD
- Ticker Symbol: NUTEX
Based on an overall assessment of its quality, value and momentum Nutex Befektetesi Nyrt is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nutex Befektetesi Nyrt. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +3.91%.
As of the last closing price of HUF19.50, shares in Nutex Befektetesi Nyrt were trading +0.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nutex Befektetesi Nyrt PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HUF19.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Nutex Befektetesi Nyrt's management team is headed by:
- Gabor Csereklei - DRC
- Vilmos Galamb - DRC
- Dora Kopros - DRC